These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7328998)
41. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model]. Leinweber B; Mahrt R Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192 [No Abstract] [Full Text] [Related]
43. [Drug-induced hepatits: the role of unstable metabolites (author's transl)]. Pessayre D; Benhamou JP Acta Gastroenterol Belg; 1978; 41(9-10):574-86. PubMed ID: 735686 [No Abstract] [Full Text] [Related]
44. [The results of liver biopsies during rifampicin therapy (author's transl)]. Kozma D; Lapis K; Tompa A Prax Pneumol; 1976 Dec; 30(12):764-70. PubMed ID: 1013060 [No Abstract] [Full Text] [Related]
45. [Hepatitis induced by combined rifomycin and isoniazid]. Marche J; Hugues FC; Graisely B; Marche C Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5150725 [No Abstract] [Full Text] [Related]
46. [Clinico-pathological features and possible pathogenesis of rifampicin-induced acute renal failure]. Li X; Wang Y; Zhao M; Zhu Y; Liu Y; Wang H Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):370-3. PubMed ID: 11798598 [TBL] [Abstract][Full Text] [Related]
47. Hepatotoxicity of isoniazid and rifampin in children. Rugmini PS; Mehta S Indian Pediatr; 1984 Feb; 21(2):119-26. PubMed ID: 6469294 [No Abstract] [Full Text] [Related]
48. Hepatitis from isoniazid and rifampin. Groopman JE; Soloff L; Tessler S N Engl J Med; 1978 Jun; 298(23):1316-7. PubMed ID: 651986 [No Abstract] [Full Text] [Related]
49. [Acute renal failure, intravascular hemolysis and toxic hepatitis caused by repeated use of rifampicin (case report)]. Sefer S; Ivanusa M; Kes P; Ratković-Gusić I; Vasilj D Lijec Vjesn; 1999; 121(4-5):126-8. PubMed ID: 10437356 [TBL] [Abstract][Full Text] [Related]
51. Acute renal failure caused by rifampicin re-exposure with 10-year of interval. Tsai TL; Lee CH; Chuang FR; Hsu KT Chang Gung Med J; 2001 Nov; 24(11):729-33. PubMed ID: 11820654 [TBL] [Abstract][Full Text] [Related]
52. Hepatorenal failure with self-initiated intermittent rifampicin therapy. Rothwell DL; Richmond DE Br Med J; 1974 Jun; 2(5917):481-2. PubMed ID: 4834100 [No Abstract] [Full Text] [Related]
53. [Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin]. Waitzberg VR; Gayotto LC Rev Hosp Clin Fac Med Sao Paulo; 1982 Feb; 37(1):48-51. PubMed ID: 7123064 [No Abstract] [Full Text] [Related]
54. [Hepatotoxicity of rifampicin-rifamycin SV in the treatment of tuberculous meningitis (author's transl)]. Ziebart-Schroth A Wien Klin Wochenschr; 1973 Oct; 85(42):692-5. PubMed ID: 4128922 [No Abstract] [Full Text] [Related]
55. [Detection of the effects of the rifampin-isoniazid combination on the human liver]. Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506 [No Abstract] [Full Text] [Related]
57. [Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)]. Deck KA; Gehrhardt A; Klein HO; Ludes H Med Klin; 1976 Oct; 71(43):1836-41. PubMed ID: 995024 [TBL] [Abstract][Full Text] [Related]
59. Acute renal failure and severe thrombocytopenia induced by rifampicin: report of a case. Juang YC; Tsao TC; Chiang YC; Lin JL; Tsai YH J Formos Med Assoc; 1992 Apr; 91(4):475-6. PubMed ID: 1358323 [TBL] [Abstract][Full Text] [Related]
60. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide]. Chioléro R Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]